Matches in Wikidata for { <http://www.wikidata.org/entity/Q74130391> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q74130391 description "article scientifique publié en août 2000" @default.
- Q74130391 description "artículu científicu espublizáu n'agostu de 2000" @default.
- Q74130391 description "im August 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q74130391 description "scientific article published on 01 August 2000" @default.
- Q74130391 description "wetenschappelijk artikel" @default.
- Q74130391 description "наукова стаття, опублікована в серпні 2000" @default.
- Q74130391 name "Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-alpha for the treatment of patients with advanced renal cell carcinoma: a southwest oncology group Phase II study" @default.
- Q74130391 name "Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-alpha for the treatment of patients with advanced renal cell carcinoma: a southwest oncology group Phase II study" @default.
- Q74130391 type Item @default.
- Q74130391 label "Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-alpha for the treatment of patients with advanced renal cell carcinoma: a southwest oncology group Phase II study" @default.
- Q74130391 label "Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-alpha for the treatment of patients with advanced renal cell carcinoma: a southwest oncology group Phase II study" @default.
- Q74130391 prefLabel "Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-alpha for the treatment of patients with advanced renal cell carcinoma: a southwest oncology group Phase II study" @default.
- Q74130391 prefLabel "Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-alpha for the treatment of patients with advanced renal cell carcinoma: a southwest oncology group Phase II study" @default.
- Q74130391 P1433 Q74130391-EDD48568-B605-4BD7-8357-5C3385C4570F @default.
- Q74130391 P1476 Q74130391-D0F7962A-6C2B-40B5-95FE-D94DDF7047EB @default.
- Q74130391 P2093 Q74130391-16FF4BF3-B2A9-4132-B88C-27696C364F3F @default.
- Q74130391 P2093 Q74130391-390422AC-067F-479B-870F-472807E52ACB @default.
- Q74130391 P2093 Q74130391-45F02E01-B277-4B82-B946-8551A992B2E3 @default.
- Q74130391 P2093 Q74130391-5853339C-F188-42FD-9974-4A35B4A0030B @default.
- Q74130391 P2093 Q74130391-86856EF4-9897-48C1-BFDE-85AF204DA53A @default.
- Q74130391 P2093 Q74130391-AA8398B9-4C69-45E8-B248-F91CA91DD5B1 @default.
- Q74130391 P2093 Q74130391-CF469A41-5F3A-49D1-9DE6-275089E667E5 @default.
- Q74130391 P2093 Q74130391-D63698A2-BF8A-4D5B-8597-9CB3676C7227 @default.
- Q74130391 P2093 Q74130391-DD33CFE0-4AFE-41CC-B9A7-9141CD5D76F9 @default.
- Q74130391 P2093 Q74130391-EE7F9B06-778A-44D6-B88A-27615643727C @default.
- Q74130391 P304 Q74130391-A923B682-C2C4-403D-91CA-8CB42C6FC28C @default.
- Q74130391 P31 Q74130391-1C71D9FB-4837-44A2-8AB0-FC2BC170D091 @default.
- Q74130391 P356 Q74130391-C260DAB8-E8DD-4F08-9DCB-957141BF048D @default.
- Q74130391 P407 Q74130391-F91D76C1-2836-4B97-8541-867537EBA983 @default.
- Q74130391 P433 Q74130391-6D732ED9-D9EA-4D28-A251-2762C6043A9D @default.
- Q74130391 P478 Q74130391-1A36CE2F-B8A5-4F43-AB80-573B03D0BC72 @default.
- Q74130391 P577 Q74130391-19F7586C-F90D-4C60-834E-238C57B21917 @default.
- Q74130391 P698 Q74130391-609122CF-C41C-4FC1-AB38-6512F2F63329 @default.
- Q74130391 P921 Q74130391-1428C404-81BB-4D8A-A900-640CD352D888 @default.
- Q74130391 P921 Q74130391-28B67752-DDC2-4ACA-8556-403ECFB7E414 @default.
- Q74130391 P356 1097-0142(20000801)89:3%3C597::AID-CNCR15%3E3.0.CO;2-E @default.
- Q74130391 P698 10931459 @default.
- Q74130391 P1433 Q326041 @default.
- Q74130391 P1476 "Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-alpha for the treatment of patients with advanced renal cell carcinoma: a southwest oncology group Phase II study" @default.
- Q74130391 P2093 "D Lew" @default.
- Q74130391 P2093 "D P Wood" @default.
- Q74130391 P2093 "E David" @default.
- Q74130391 P2093 "L Elias" @default.
- Q74130391 P2093 "M E Thompson" @default.
- Q74130391 P2093 "P L Triozzi" @default.
- Q74130391 P2093 "R A Figlin" @default.
- Q74130391 P2093 "R C Flanigan" @default.
- Q74130391 P2093 "R J Belt" @default.
- Q74130391 P2093 "S E Rivkin" @default.
- Q74130391 P304 "597-603" @default.
- Q74130391 P31 Q13442814 @default.
- Q74130391 P356 "10.1002/1097-0142(20000801)89:3<597::AID-CNCR15>3.0.CO;2-E" @default.
- Q74130391 P407 Q1860 @default.
- Q74130391 P433 "3" @default.
- Q74130391 P478 "89" @default.
- Q74130391 P577 "2000-08-01T00:00:00Z" @default.
- Q74130391 P698 "10931459" @default.
- Q74130391 P921 Q1164529 @default.
- Q74130391 P921 Q238512 @default.